+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aliqopa"

Follicular Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Follicular Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 129 Pages
  • Global
From
Aliqopa - Drug Insight and Market Forecast, 2030 - Product Thumbnail Image

Aliqopa - Drug Insight and Market Forecast, 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
Aliqopa - Product Thumbnail Image

Aliqopa

  • Report
  • January 2019
  • 18 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Aliqopa market is a subset of the larger lymphoma drug market, focusing on the development and commercialization of drugs for the treatment of B-cell non-Hodgkin lymphoma (NHL). Aliqopa is a monoclonal antibody that targets the CD20 antigen on B-cells, and is used in combination with chemotherapy to treat NHL. The Aliqopa market is characterized by a high degree of competition, with several companies developing and marketing similar drugs. The market is also characterized by a high degree of innovation, with companies developing new drugs and formulations to improve efficacy and safety. Companies in the Aliqopa market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Genentech, Janssen, Merck, Novartis, and Pfizer. Show Less Read more